NextCure NXTC
NASDAQ NXTC
$4.98 +0.26 (+5.51%)
At close: Oct 23, 2026 · 4:00 PM EDT

NextCure (NXTC) Other Accumulated Expenses (2019 - 2025)

Updated

NextCure's Other Accumulated Expenses was $135,000 in Q4 2025, up 8.9% from $124,000 a year earlier.

Analysis

NextCure (NXTC) Other Accumulated Expenses (2019 - 2025) Analysis & Trends

From Q4 2018 onward, NextCure has reported Other Accumulated Expenses for 8 quarters.

  • Other Accumulated Expenses has now increased for three consecutive years, with a five-year compound annual growth rate of 59.7% (FY2020 to FY2025).
  • In earlier years, Other Accumulated Expenses was $124,000 in FY2024 (+9.7%), $113,000 in FY2023 (+7.6%), $105,000 in FY2022 (-51.6%) and $217,000 in FY2021.
  • The Q4 2025 figure marks the highest quarterly Other Accumulated Expenses since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 NextCure 26.44 Mn -94.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 135,000.00
Dec 31, 2024 124,000.00
Dec 31, 2023 113,000.00
Dec 31, 2022 105,000.00
Dec 31, 2021 217,000.00
Dec 31, 2020 13,000.00
Dec 31, 2019 154,000.00
API Access

NextCure Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NXTC&period=max&api_key=YOUR_API_KEY